[su_dropcap style="flat"]T[/su_dropcap]he pharma industry in India is entering a very interesting variant of the post-digital marketing era. The term “post-digital marketing” is used to depict a state where the lines between physical and digital blur considerably for a customer. However, in the context of pharma, this means a state where the industry has stopped questioning the need for digital and has begun to implement very interesting digital marketing initiatives.
DigiStorm has always been about practising managers sharing their successes and failures and the lessons learned from them, than about theory and concepts.
At DigiStorm 2018 in Bengaluru, the sessions were lined up to explore how pharma is dealing with the post-digital marketing world. DigiStorm has always been about practising managers sharing their successes and failures and the lessons learned from them, than about theory and concepts. Built on a framework of Intent, Content, Strategy and Skills – DigiStorm hosted several CEOs, VPs, BU heads and Marketing/Sales heads who not only shared their experiences on the dais but also comprised the large audience that benefited from the discussions.
Competing Successfully in the Digital Economy
Following on from the highly interactive and eventful CEO Round Table which established the need for top-down engagement and involvement of the C-suite in an organization’s journey into technology and transformation, the second session dealt with VP-Marketing and BU Heads discussing their ‘on-the-ground’ experiences in taking the CEO’s vision forward in terms of execution.





